Meet Courtney

“Throughout my life, my hemophilia A has been dismissed, and I haven’t always received the care I needed. My mom decided to have a prenatal test when she was pregnant with me after my older brother, Derek, was diagnosed with hemophilia during his birth. She learned that I was a carrier for hemophilia, but I didn’t receive a diagnosis for mild hemophilia until I was 10. Even then, the doctor said, “She’s female, so she’s only going to need factor for surgeries and childbirth, or if she ever gets injured or in a major car accident.”

However, it didn’t feel that mild when I got my period a couple years later; it lasted 2 weeks and I kept bleeding through my shorts. Or when I competed in cheer and dance, and a sprained ankle required on-demand treatment. When preparing for the birth of each of my 3 children, I made a plan with my doctor so we would be prepared during and all through recovery.  

But still my factor levels weren’t where they needed to be. That’s when my brother told me about ALTUVIIIO. I learned that ALTUVIIIO was shown to offer higher-for-longer factor levels in the near-normal to normal range, over 40%, for most of the week in adults. It also showed a 48-hour half-life in adults. I asked my hematologist about ALTUVIIIO, and he agreed I should give it a try. I started taking ALTUVIIIO prophylactically in May of 2023. 

My hope is that as awareness of hemophilia increases, more people will learn about how it can impact women as well as men, and can have significant consequences if not treated properly. I am grateful I live in a time where there is a treatment available to me.”

Courtney is a promotional speaker compensated by Sanofi.